Merck CEO and R&D chief to join Morgan Stanley healthcare fireside chat
Merck invited listeners to a live audio webcast of a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Sept. 14, 2026 at 3:20 p.m. Robert M. Davis, chairman and CEO, and Dr. Dean Y. Li, executive vice president and president of Merck Research Laboratories, are scheduled to participate. The company also reiterated its research-intensive biopharmaceutical focus and forward-looking statement risk disclosures.